Urinary circRNA hsa_circ_0001334: a potential non-invasive early indicator of subsequent renal allograft rejection
Molecular Biology Reports · 2026
DOI: 10.1007/s11033-026-13047-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Samar Bizhani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: RNA, Circular, Kidney Transplantation, Graft Rejection. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Shiraz University of Medical Sciences.
Abstract (Originalsprache)
BACKGROUND: Kidney allograft rejection is a major cause of graft loss. The need for non‑invasive biomarkers to complement invasive biopsy is urgent. Circular RNAs (circRNAs) are stable regulatory molecules that function as microRNA (miRNA) sponges within competitive endogenous RNA (ceRNA) networks, making them promising candidates for non-invasive biomarker development. This study aimed to investigate whether early postoperative expression of specific ceRNA axes, particularly hsa_circ_0001334/hsa-miR‑665/CNR2, is associated with subsequent kidney transplant rejection. METHODS AND RESULTS: We enrolled 52 subjects; 15 recipients with biopsy‑proven rejection, 17 clinically stable recipients, and 20 healthy controls. Using SYBR Green‑based quantitative real‑time PCR, we measured expression of hsa_circ_0001334, hsa_circ_0071475, their host genes (MCM2, TNM3), related miRNAs (hsa-miR‑665, hsa-miR‑1208, hsa-miR‑1183), and target mRNAs (CNR2, ADORA2B) in paired urine and blood samples. Non‑parametric tests, Spearman correlation, and receiver‑operating‑characteristic (ROC) curve analysis were employed. Urinary hsa_circ_0001334 was markedly upregulated in the subsequent rejection group (p < 0.0001), whereas its linear host gene MCM2 remained unchanged. hsa_circ_0071475 showed only a modest elevation compared to healthy controls and no change in blood. An expression pattern consistent with a putative ceRNA relationship was observed, with lower urinary hsa-miR-665 expression and higher CNR2 expression in recipients who subsequently developed biopsy-proven rejection. ROC analysis demonstrated excellent preliminary predictive discrimination for urinary hsa_circ_0001334, with an area under the curve (AUC) of 1.00 (p = 0.0006). CONCLUSION: Our findings suggest a potential involvement of the hsa_circ_0001334/hsa-miR-665/CNR2 axis in immune-mediated injury during kidney allograft rejection. Urinary hsa_circ_0001334 may serve as a potential non-invasive biomarker for early risk stratification of subsequent rejection, though further validation in larger independent cohorts and functional studies are required to confirm its clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
- Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. afsafshari@yahoo.com.
- Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Afsoon Afshari
Förderung
- Shiraz University of Medical Sciences
Zitieren
APA
Bizhani, S., Afshari, A., Yaghobi, R., & Roozbeh, J. (2026). Urinary circRNA hsa_circ_0001334: a potential non-invasive early indicator of subsequent renal allograft rejection. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-13047-4
Vancouver
Bizhani S, Afshari A, Yaghobi R, Roozbeh J. Urinary circRNA hsa_circ_0001334: a potential non-invasive early indicator of subsequent renal allograft rejection. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-13047-4
BibTeX
@article{Bizhani2026,
author = {Bizhani, Samar and Afshari, Afsoon and Yaghobi, Ramin and Roozbeh, Jamshid},
title = {Urinary circRNA hsa_circ_0001334: a potential non-invasive early indicator of subsequent renal allograft rejection},
journal = {Molecular Biology Reports},
year = {2026},
doi = {10.1007/s11033-026-13047-4}
}
EUVIMED